Discrepancies of NKT cells expression in peripheral blood and in cerebrospinal fluid from Behçet's disease

Journal of Neuroimmunology

Volumn 175, Issue 1-2, 2006, Pages 160-168

  Hamzaoui, Kamel ^a   Kamoun, Mariam ^a   Houman, Habib ^b   Hentati, Fayçal ^b   Hamza, M'Hamed ^c   Ayed, Khaled ^d   Hamzaoui, Agnes ^a,e  

^a UNIVERSITY OF TUNIS   (Tunisia)

^b LA RABTA HOSPITAL   (Tunisia)

^c Rheumatic Department   (Tunisia)

^d CHARLES NICOLLE HOSPITAL   (Tunisia)

^e ABDERRAHMAN MAMI HOSPITAL   (Tunisia)

Author keywords

Beh et's disease; Cerebrospinal fluid; Inflammation; NKT cells; Th1 cytokines

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; ALPHA-GALACTOSYLCERAMIDE; GALACTOSYLCERAMIDE;

ADULT; ARTICLE; BEHCET DISEASE; CEREBROSPINAL FLUID; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; STATISTICAL ANALYSIS; BIOSYNTHESIS; BLOOD; CELL CULTURE; COMPARATIVE STUDY; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; LYMPHOCYTE COUNT; METABOLISM; MIDDLE AGED; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION;

ADULT; BEHCET SYNDROME; CELLS, CULTURED; FEMALE; GALACTOSYLCERAMIDES; GENE EXPRESSION PROFILING; HUMANS; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS;

EID: 33746303610     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.02.011     Document Type: Article

References (47)

1. Akman-Demir G., Serdaroglu P., Tasci B., and and The Neuro-Behçet Study Group. Clinical patterns of neurological involvement in Behçet's disease. Evaluation of 200 patients. Brain 122 (1999) 2171-2182
2. Alper G., Yi{dotless}lmaz Y., Ekinci G., and Köse O. Cerebral vein thrombosis in Behçet's disease. Pediatr. Neurol. 25 (2001) 332-335
3. Araki M., Kondo T., Gumperz J.E., Brenner M.B., Miyake S., and Yamamura T. T(h)2 bias of CD4(+) NKT cells derived from multiple sclerosis in remission. Int. Immunol. 15 (2003) 279-288
4. Bendelac A., Rivera M.N., Park S.H., and Roark J.N. Mouse Cd1-specific NKT cells: development, specificity and function. Annu. Rev. Immunol. 15 (1997) 535-562
5. Benoist C., and Mathis D. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry?. Nat. Immunol. 2 (2001) 797-801
6. Bix M., and Locksley R.M. Natural T cells: cells that co-express NKRP-1 and TCR. J. Immunol. 155 (1995) 1020-1022
7. Cui J., Shin T., Kawano T., Sato H., Kondo E., Toura I., Kaneko, Koseki Y.H., Kanno M., and Taniguchi M. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 278 (1997) 1623-1626
8. Cui J., Watanabe N., Kawano T., Yamashita M., Kamata T., Shimizu C., Kimura M., Shimizu E., Koike J., Koseki H., Tanaka Y., Taniguchi M., and Nakayama T. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Vα14 natural killer T cells. J. Exp. Med. 190 (1999) 783-792
9. 1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum. 42 (1999) 1967-1974
10. Freysdottir J., Lau S., and Fortune F. Gamma delta T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS). Clin. Exp. Immunol. 118 (1999) 451-457
11. Fujii S., Shimizu K., Kronenberg M., and Steinman R.M. Prolonged IFN-γ-producing NKT response induced with alpha-galactosylceramide-loaded DCs. Nat. Immunol. 3 (2002) 867-874
12. Furlan R., Bergami A., Cantarella D., Brambilla E., Taniguchi M., Dellabona P., Casorati G., and Martino G. Activation of invariant NKT cells by αGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma. Eur. J. Immunol. 33 (2003) 1830-1838
13. Godfrey D.I., Hammond K.J., Poulton L.D., Smyth M.J., and Baxter A.G. NKT cells: facts, functions and fallacies. Immunol. Today 21 (2000) 573-583
14. Hamzaoui A., and Hamzaoui K. Manifestations thoraciques des maladies de Behçet et de Takayasu. Rev. Mal. Respir. 22 (2005) 999-1019
15. Hamzaoui K., Ayed K., Slim A., Hamza M., and Touraine J. Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behçet's disease. Clin. Exp. Immunol. 79 (1990) 28-34
16. Hamzaoui K., Hamzaoui A., Hentati F., Kahan A., Ayed K., Chabbou A., Ben Hamida M., and Hamza M. Phenotype and functional profile of T cells expressing gamma delta receptor from patients with active Behçet's disease. J. Rheumatol. 21 (1994) 2301-2306
17. Hamzaoui K., Hamzaoui A., Guemira F., Bessioud M., Hamza M., and Ayed K. Cytokine profile in Behçet's disease patients. Relationship with disease activity. Scand. J. Rheumatol. 31 (2002) 205-210
18. Hamzaoui K., Hamzaoui A., Bouajina L., and Houman H. Circulating soluble CD28 in patients with Behçet's disease: relationship to clinical manifestations. Clin. Exp. Rheumatol. 23 (2005) S49-S52
19. Hirohata S., and Kikuchi H. Behçet's disease. Arthritis Res. 5 (2003) 139-146
20. International Study Group for Behçet's disease. Criteria for diagnosis of Behçet's disease. Lancet 335 (1990) 1078-1080
21. Jahng A.W., Maricic I., Pedersen B., Burdin N., Naidenko O., Kronenberg M., Koezuka Y., and Kumar V. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J. Exp. Med. 194 (2001) 1789-1799
22. + T cells in IL-12-induced immune responses in vivo. J. Immunol. 160 (1998) 16-19
23. Kibaroglu A., Eksioglu-Demiralp E., Akoglu T., and Direskeneli H. T and NK cell subset changes with microbial extracts and human HSP60-derived peptides in Behçet's disease. Clin. Exp. Rheumatol. 22 Suppl. 34 (2004) S59-S63
24. Kidd D. Neurologica complications of Behçet's syndrome. ACNR 3 (2003) 8-11
25. + double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum. 44 (2001) 1127-1138
26. Kojo S., Tsutsumi A., Goto D., and Sumida T. Low expression levels of soluble CD1d gene in patients with rheumatoid arthritis. J. Rheumatol. 30 (2003) 2524-2528
27. 2 shift circumscribed regionally to the islets and functionally to islet autoantigen. J. Immunol. 166 (2001) 3749-3756
28. Lawton G., Bhakta B.B., Chamberlain A., and Tenant A. The Behçet's disease activity index. Rheumatology 43 (2004) 73-78
29. 1-like phenotype in rheumatoid arthritis. Arthritis Res. Ther. 7 (2005) 493-501
30. Marshall S.E. Behçet's disease. Best Pract. Res., Clin. Rheumatol. 18 (2004) 291-311
31. Matsumoto Y.K., Kohyama Y., Aikawa T., Shin, Kawazoe Y., and Suzuki Y. Role of natural killer cells and TCR γδ T cells in acute autoimmune encephalomyelitis. Eur. J. Immunol. 28 (1998) 1681-1688
32. Nokher W.A., Wick M., and Pfister H.W. Cerebrospinal fluid levels of soluble CD14 in inflammatory and non-inflammatory diseases of the CNS: upregulation during bacterial infections and viral meningitis. J. Neuroimmunol. 101 (1999) 161-169
33. Sakane T., Suzuki N., and Nagafuchi H. Etiopathology of Behçet's disease: immunological aspects. Yonsei Med. J. 38 (1997) 350-358
34. Saruhan-Direskeneli G., Yentur S.P., Akman-Demir G., Isik N., and Serdaroglu P. Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases. J. Neuroimmunol. 145 (2003) 127-134
35. Shao H., Van Kaer L., Sun S.L., Kaplan H.J., and Sun D. Infiltration of the inflamed eye by NKT cells in a rat model of experimental autoimmune uveitis. J. Autoimmun. 21 (2003) 37-45
36. 2 phenotype. J. Immunol. 163 (1999) 2373-2377
37. Singh A.K., Wilson M.T., Hong S., Olivares-Villagomez D., Du C., Stanic A.K., Joyce S., Sriram S., Koezuka Y., and Van Kaer L. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 194 (2001) 1801-1811
38. Smyth M.J., Thia K.Y., Street S.E., Cretney E., Trapani J.A., Taniguchi M., Kawano T., Pelikan S.B., Crowe N.Y., and Godfrey D.I. Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med. 191 (2000) 661-668
39. Suzuki Y., Onodera H., Tago H., Saito R., Ohuchi M., Shimizu M., and Itoyama Y. Altered populations of natural killer cell and natural killer T cell subclasses in myasthenia gravis. J. Neuroimmunol. 167 1-2 (2005) 186-189
40. 1-type inflammatory homing cells. J. Immunol. 171 (2003) 2571-2580
41. Van der Aa, Hellings N., Bernard C.C., Raus J., and Stinissen P. Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls. J. Neuroimmunol. 137 (2003) 164-176
42. + NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin. Immunol. 100 (2001) 144-148
43. 1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature 391 (1998) 177-181
44. Yazici H. The place of Behçet's syndrome among the autoimmune diseases. Int. Rev. Immunol. 14 (1997) 1-10
45. + T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179 (1994) 1285-1295
46. 2 response and in immunoglobulin E production. Science 270 (1995) 1845-1847
47. + T cells and NKT cells increases in the aqueous humor of patients with Behçet's uveitis. Clin. Exp. Immunol. 137 (2004) 437-443